SNTI Senti Biosciences Inc.
Price (delayed)
$3.21
Market cap
$83.47M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$12.03
Enterprise value
$65.3M
Highlights
The quick ratio has surged by 153% since the previous quarter and by 27% year-on-year
SNTI's net income is up by 26% YoY and by 26% from the previous quarter
Senti Biosciences's equity has shrunk by 62% YoY but it has surged by 60% QoQ
SNTI's gross profit has dropped by 100% year-on-year
The revenue has plunged by 100% YoY
Key stats
What are the main financial stats of SNTI
Market
Valuations
Earnings
Shares outstanding
26M
Market cap
$83.47M
Enterprise value
$65.3M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.57
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$61.04M
Net income
-$52.79M
EBIT
-$52.79M
EBITDA
-$46.94M
Free cash flow
-$41.36M
Per share
Balance sheet
Liquidity
EPS
-$12.03
EPS diluted
-$12.03
Free cash flow per share
-$9
Book value per share
$5.59
Revenue per share
$0
TBVPS
$21.29
Total assets
$97.84M
Total liabilities
$47.09M
Debt
$33.64M
Equity
$25.65M
Working capital
$45.82M
Debt to equity
1.31
Current ratio
4.49
Quick ratio
3.95
Net debt/EBITDA
0.39
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-61.3%
Return on equity
-148.8%
Return on invested capital
-63.7%
Return on capital employed
-62.3%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
SNTI stock price
How has the Senti Biosciences stock price performed over time
Intraday
-1.05%
1 week
-9.58%
1 month
6.64%
1 year
-8.02%
YTD
-8.55%
QTD
-4.46%
Financial performance
How have Senti Biosciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$61.04M
Net income
-$52.79M
Gross margin
N/A
Net margin
N/A
SNTI's gross profit has dropped by 100% year-on-year
The revenue has plunged by 100% YoY
SNTI's operating income is up by 34% year-on-year and by 4% since the previous quarter
SNTI's net income is up by 26% YoY and by 26% from the previous quarter
Growth
What is Senti Biosciences's growth rate over time
Valuation
What is Senti Biosciences stock price valuation
P/E
N/A
P/B
0.57
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
SNTI's EPS is up by 25% year-on-year and by 23% since the previous quarter
Senti Biosciences's equity has shrunk by 62% YoY but it has surged by 60% QoQ
SNTI's P/B is 16% above its last 4 quarters average of 0.5
The revenue has plunged by 100% YoY
Efficiency
How efficient is Senti Biosciences business performance
The ROE has plunged by 88% YoY but it has grown by 3.9% from the previous quarter
The ROA has grown by 21% from the previous quarter but it has contracted by 20% YoY
The ROIC is up by 17% since the previous quarter but it is down by 12% year-on-year
Dividends
What is SNTI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for SNTI.
Financial health
How did Senti Biosciences financials performed over time
The company's total assets is 108% higher than its total liabilities
The quick ratio has surged by 153% since the previous quarter and by 27% year-on-year
SNTI's current ratio has soared by 134% since the previous quarter but it is down by 20% year-on-year
The debt is 31% more than the equity
SNTI's debt to equity has surged by 134% year-on-year but it is down by 40% since the previous quarter
Senti Biosciences's equity has shrunk by 62% YoY but it has surged by 60% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.